Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
2023 · New England Journal of Medicine · 770 citations
https://doi.org/10.1056/nejmoa2215024
M
Michael J. Louie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
4.4K
Citations
30
h-index
50
i10-index
Michael J. Louie is an academic researcher from Princeton University. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Health Systems, Economic Evaluations, Quality of Life & Bladder and Urothelial Cancer Treatments. The author has an h-index of 30, co-authored 112 publications.
ORCID: 0000-0001-5464-8986Papers by this author
worksPatient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
2019 · Journal of the American Heart Association · 279 citations
https://doi.org/10.1161/jaha.118.011765
Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)
2016 · The American Journal of Cardiology · 127 citations
https://doi.org/10.1016/j.amjcard.2016.09.010
Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records
2015 · BMC Women s Health · 116 citations
https://doi.org/10.1186/s12905-015-0217-y
Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome ― The ODYSSEY J-IVUS Trial ―
2019 · Circulation Journal · 83 citations
https://doi.org/10.1253/circj.cj-19-0412
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
2023 · The Lancet Diabetes & Endocrinology · 75 citations
https://doi.org/10.1016/s2213-8587(23)00316-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat